Stock Report

Download full stock data and analysis for free Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Ayala Pharmaceuticals Inc (AYLA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.50

$0.00 (0.00%)

As on 27-Jan-2023 09:30EDT

Market cap

info icon

$8 Mln

Revenue (TTM)

info icon

$2 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 139.47 -85.44 -48.48 -- --
EBIT -17,484.48 -4.03 19.62 -240.58 --
Net Profit -6,430.77 -4.00 23.19 -236.38 --
EPS -6,430.77 2.93 34.10 -- --
Book Value -- -- -36.46 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -903.28---1,803.17-1,170.28-800.03
Net Margin info -----1,755.34----
Return on equity info 85.15---184.49-110.96-114.08
Return on Capital info 92.77-----110.12-112.27
Return on Assets info -112.48---85.00-170.51-91.52
Debt to Equity (x) info ----0.00--0.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
-110.12
-112.27
500.69
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-184.49

Lower than Peers by 158.18

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-184.49
-110.96
-114.08
480.48
--
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-85.00

Lower than Peers by 72.04

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-85.00
-170.51
-91.52
-75.42
--
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-1,803.17

Lower than Peers by 1,743.47

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-1,803.17
-1,170.28
-800.03
-739.55
--
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-1,755.34

Lower than Peers by 1,684.28

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-1,755.34
-1,148.15
-813.00
-762.30
--
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.01

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-0.01
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-48.48

Lower than Peers by 69.04

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-48.48
-0.05
0.59
--
--
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

19.62

Higher than Peers by 4.42

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
19.62
-38.31
-71.86
-101.01
--
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

23.19

Higher than Peers by 15.33

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
23.19
-33.53
-69.44
-100.52
--
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

34.10

Higher than Peers by 3.64

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
34.10
0.05
0.15
--
--
Peer Median
30.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-80.66

Lower than Peers by 81.91

Year on year growth in book value per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-80.66
--
--
--
--
Peer Median
1.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
--
0.01
0.02
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.28

Lower than Peers by 1.20

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
2.28
6.14
6.43
3.34
9.68
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.28

Lower than Peers by 1.00

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
2.28
--
--
--
--
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-217.30

Lower than Peers by 215.79

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
-217.30
-157.81
-529.73
-76.72
--
Peer Median
-1.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

7.44

Lower than Peers by 16.89

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
7.44
--
18.37
20.09
--
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.05

Lower than Peers by 0.18

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
0.05
0.15
0.11
0.10
--
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
35.47
56.64
36.70
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
361.50
327.42
550.43
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
-2.96
-3.65
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.02

Lower than Peers by 3.94

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
1.02
3.49
2.86
--
--
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

0.07

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
0.07
-2.01
-2.32
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

8

Lower than Peers by 75

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Ayala Pharmaceuticals Inc (AYLA)
8
--
--
--
--
Peer Median
83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...